DIASORIN: PUBLICATION OF THE SUMMARY REPORT OF THE VOTES CAST

Saluggia, October 7, 2021 - DiaSorin S.p.A. (FTSE MIB: DIA) (the "Company") hereby gives notice that, pursuant to applicable laws and regulations, the summary report of the votes cast at the extraordinary meeting of shareholders of the Company, held on 4th October 2021, was made available to the public today on the Company's corporate website (www.diasoringroup.com, section "Governance/Information for Shareholders/Shareholders meetings and board/2021".

For further information

INVESTOR RELATIONS

Riccardo Fava

Emanuela Salvini

Corporate Vice President Communication & Investor

Investor Relator

Relations

Tel: +39 0161.487988

Tel: +39 0161.487567

riccardo.fava@diasorin.it

emanuela.salvini@diasorin.it

DIASORIN

Headquartered in Italy and listed at the Italian Stock Exchange in the FTSE MIB Index, DiaSorin is a global leader in the In Vitro Diagnostic (IVD) field and is active since 2021 in the Life Science business. For over 50 years, the Company has been developing, producing and marketing reagent kits used by diagnostic laboratories worldwide. The Group operates in 5 continents through 45 companies, 4 branches, 10 manufacturing facilities and 9 research and development centres. The extensive diagnostic testing and Life Science offer, made available through continuous investments in research, positions DiaSorin as the player with the broadest range of specialty tests available within the diagnostic market, and identifies the Group as the "Diagnostic Specialist".

More info at www.diasoringroup.com.

Attachments

  • Original document
  • Permalink

Disclaimer

DiaSorin S.p.A. published this content on 07 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 October 2021 09:56:01 UTC.